Cargando…
Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL(pro) and M(pro)/ 3CL(pro): molecular docking and simulation studies of three pertinent medicinal plant natural components
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - coronavirus disease 2019 (COVID-19) has raised a severe global public health issue and creates a pandemic situation. The present work aims to study the molecular -docking and dynamic of three pertinent medicinal plant...
Autores principales: | Verma, Devvret, Mitra, Debasis, Paul, Manish, Chaudhary, Priya, Kamboj, Anshul, Thatoi, Hrudayanath, Janmeda, Pracheta, Jain, Divya, Panneerselvam, Periyasamy, Shrivastav, Rakesh, Pant, Kumud, Das Mohapatra, Pradeep K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178537/ https://www.ncbi.nlm.nih.gov/pubmed/34870149 http://dx.doi.org/10.1016/j.crphar.2021.100038 |
Ejemplares similares
-
“Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CL(pro) and PL(pro)"
por: Bhowmik, Deep, et al.
Publicado: (2021) -
Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL(PRO) and 3CL(PRO) proteases
por: Jade, Dhananjay, et al.
Publicado: (2021) -
Discovery of PL(pro) and M(pro) Inhibitors
for SARS-CoV-2
por: Puhl, Ana C., et al.
Publicado: (2023) -
An overview of potential inhibitors targeting non-structural proteins 3 (PL(pro) and Mac1) and 5 (3CL(pro)/M(pro)) of SARS-CoV-2
por: Yan, Fangfang, et al.
Publicado: (2021) -
ProCoS: Protein composition server
por: Rishishwar, Lavanya, et al.
Publicado: (2010)